Natus Medical Shares Outstanding 2006-2018 | BABY
Natus Medical shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Natus Medical Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2018 | 33 |
| 2017 | 33 |
| 2016 | 33 |
| 2015 | 33 |
| 2014 | 33 |
| 2013 | 31 |
| 2012 | 30 |
| 2011 | 29 |
| 2010 | 29 |
| 2009 | 28 |
| 2008 | 27 |
| 2007 | 23 |
| 2006 | 20 |
| 2005 | 19 |
| Natus Medical Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| Q4 2018 | 33 |
| Q3 2018 | 33 |
| Q2 2018 | 33 |
| Q1 2018 | 33 |
| Q4 2017 | 33 |
| Q3 2017 | 33 |
| Q2 2017 | 33 |
| Q1 2017 | 33 |
| Q4 2016 | 33 |
| Q3 2016 | 33 |
| Q2 2016 | 33 |
| Q1 2016 | 33 |
| Q4 2015 | 33 |
| Q3 2015 | 33 |
| Q2 2015 | 33 |
| Q1 2015 | 33 |
| Q4 2014 | 33 |
| Q3 2014 | 33 |
| Q2 2014 | 32 |
| Q1 2014 | 32 |
| Q4 2013 | 31 |
| Q3 2013 | 31 |
| Q2 2013 | 30 |
| Q1 2013 | 30 |
| Q4 2012 | 30 |
| Q3 2012 | 29 |
| Q2 2012 | 30 |
| Q1 2012 | 30 |
| Q4 2011 | 29 |
| Q3 2011 | 29 |
| Q2 2011 | 30 |
| Q1 2011 | 30 |
| Q4 2010 | 29 |
| Q3 2010 | 29 |
| Q2 2010 | 29 |
| Q1 2010 | 28 |
| Q4 2009 | 28 |
| Q3 2009 | 29 |
| Q2 2009 | 28 |
| Q1 2009 | 28 |
| Q4 2008 | 27 |
| Q3 2008 | 29 |
| Q2 2008 | 26 |
| Q1 2008 | 23 |
| Q4 2007 | 23 |
| Q3 2007 | 23 |
| Q2 2007 | 23 |
| Q1 2007 | 23 |
| Q4 2006 | 20 |
| Q3 2006 | 21 |
| Q2 2006 | 20 |
| Q1 2006 | 18 |
| Q4 2005 | 19 |
| Q3 2005 | 19 |
| Q2 2005 | 19 |
| Q1 2005 | 18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.943B | $0.531B |
| Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $101.538B | 22.68 |
| Intuitive Surgical (ISRG) | United States | $62.929B | 59.23 |
| Edwards Lifesciences (EW) | United States | $36.708B | 37.59 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.505B | 16.57 |
| IDEXX Laboratories (IDXX) | United States | $18.185B | 49.52 |
| ABIOMED (ABMD) | United States | $16.332B | 107.81 |
| Hologic (HOLX) | United States | $13.523B | 20.45 |
| Teleflex (TFX) | United States | $13.173B | 29.90 |
| DexCom (DXCM) | United States | $12.930B | 0.00 |
| Varian Medical Systems (VAR) | United States | $12.041B | 30.08 |
| STERIS (STE) | United Kingdom | $10.392B | 26.71 |
| Masimo (MASI) | United States | $6.825B | 44.26 |
| Penumbra (PEN) | United States | $5.141B | 310.42 |
| LivaNova (LIVN) | United Kingdom | $4.861B | 31.20 |
| Globus Medical (GMED) | United States | $4.688B | 29.38 |
| Integra LifeSciences Holdings (IART) | United States | $4.423B | 21.55 |
| Wright Medical Group (WMGI) | Netherlands | $3.941B | 0.00 |
| Cantel Medical (CMD) | United States | $3.599B | 35.50 |
| Inogen (INGN) | United States | $3.000B | 64.75 |
| Tandem Diabetes Care (TNDM) | United States | $2.811B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.761B | 23.10 |
| Glaukos (GKOS) | United States | $2.420B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.365B | 21.31 |
| OPKO Health (OPK) | United States | $1.612B | 0.00 |
| Nevro (NVRO) | United States | $1.461B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.358B | 216.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.244B | 35.93 |
| Accelerate Diagnostics (AXDX) | United States | $1.166B | 0.00 |
| Luminex (LMNX) | United States | $1.161B | 53.14 |
| CryoLife (CRY) | United States | $1.098B | 118.84 |
| Pacific Biosciences Of California (PACB) | United States | $1.088B | 0.00 |
| Intersect ENT (XENT) | United States | $1.039B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.900B | 36.80 |
| AngioDynamics (ANGO) | United States | $0.871B | 28.24 |
| ViewRay (VRAY) | United States | $0.791B | 0.00 |
| Veracyte (VCYT) | United States | $0.771B | 0.00 |
| AxoGen (AXGN) | United States | $0.677B | 0.00 |
| TransEnterix (TRXC) | United States | $0.653B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.640B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.488B | 0.00 |
| Si-Bone (SIBN) | United States | $0.466B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.457B | 0.00 |
| Accuray (ARAY) | United States | $0.454B | 0.00 |
| Fluidigm (FLDM) | United States | $0.424B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.377B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.344B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.324B | 0.00 |
| Neuronetics (STIM) | United States | $0.310B | 0.00 |
| Sientra (SIEN) | United States | $0.304B | 0.00 |
| IRadimed (IRMD) | United States | $0.292B | 62.14 |
| RTI Surgical (RTIX) | United States | $0.291B | 46.70 |
| Corindus Vascular Robotics (CVRS) | United States | $0.251B | 0.00 |
| Nuvectra (NVTR) | United States | $0.250B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.234B | 40.63 |
| Helius Medical Technologies (HSDT) | United States | $0.173B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.163B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.126B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.120B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.093B | 0.00 |
| ConforMIS (CFMS) | United States | $0.089B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.087B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.083B | 0.00 |
| EDAP TMS (EDAP) | France | $0.081B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.081B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.068B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.061B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.057B | 0.00 |
| Vermillion (VRML) | United States | $0.054B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.050B | 0.00 |
| Electromed (ELMD) | United States | $0.047B | 24.13 |
| Xtant Medical Holdings (XTNT) | United States | $0.045B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.034B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.033B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.027B | 0.00 |
| PAVmed (PAVM) | United States | $0.026B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.025B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.023B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.022B | 0.00 |
| Neovasc (NVCN) | Canada | $0.019B | 0.00 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.015B | 47.67 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 11.13 |
| Nanovibronix (NAOV) | United States | $0.012B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.011B | 0.00 |
| Presbia (LENS) | Ireland | $0.009B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.009B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| InspireMD (NSPR) | Israel | $0.008B | 0.00 |
| Micron Solutions (MICR) | United States | $0.007B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
